Ken Griffin’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
Other funds holding PCVX
Ken Griffin's PCVX Position: Q3 2026 in Review
Ken Griffin opened a new position in Vaxcyte (PCVX) in Q3 2026: 154,204 shares worth $8.77M. The stake represents ﹤0.01% of the portfolio and ranks #3857 among its holdings. This is a return to the name: Ken Griffin previously reported a position in PCVX as recently as Q4 2025.
Ken Griffin first reported a position in PCVX in Q2 2020 and has held it in 21 quarters since. The position peaked at $40.8M in Q4 2022. 356 funds tracked by Wall St. Rank hold PCVX as of Q3 2026.
- Ken Griffin held 154,204 shares of Vaxcyte worth $8.77M as of Q3 2026.
- Vaxcyte was a new Ken Griffin position in Q3 2026.
- Vaxcyte made up ﹤0.01% of Ken Griffin's portfolio in Q3 2026, its #3857 holding.
- Ken Griffin first reported a position in Vaxcyte in Q2 2020 and has held it in 21 quarters since.
- Ken Griffin's Vaxcyte position peaked at $40.8M in Q4 2022.
- 356 funds tracked by Wall St. Rank held Vaxcyte as of Q3 2026.
Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.